<p>Referent group: never-users of metformin; HR: hazard ratio, CI: confidence interval.</p><p>Models I: Fully adjusted models conducted in the whole cohort.</p><p>Models II: Fully adjusted models conducted after excluding users of both metformin and sulfonylurea.</p><p>Models III: Fully adjusted models conducted after excluding users of antidiabetic drugs other than metformin.</p><p>Metformin exposure at entry and hazard ratios for thyroid cancer.</p
BACKGROUND: Previous studies provide conflicting evidence on whether metformin is protective against...
Previous studies on metformin use and gastrointestinal (GI) cancer risk have yielded inconclusive re...
<p>Subgroup analysis of adjusted hazard ratios (HRs) of risk factors for metformin-related mortality...
<p>Referent group: never-users of metformin.</p><p>HR: hazard ratio, CI: confidence interval.</p><p>...
OBJECTIVEdNumerous studies have suggested a decreased risk of cancer in patients with diabetes on me...
OBJECTIVEdNumerous studies have suggested a decreased risk of cancer in patients with diabetes on me...
Whether metformin may affect thyroid cancer risk has not been studied. This study investigated the a...
BACKGROUND: Whether metformin may affect thyroid cancer risk has not been studied. This study invest...
*<p>CI denotes confidence interval.</p>†<p>The current cumulative exposure period is the number of m...
[[abstract]]BACKGROUND: Whether metformin may affect thyroid cancer risk has not been studied. This ...
*<p>CI denotes confidence interval.</p>†<p>The current cumulative exposure period is the number of m...
OBJECTIVE-Numerous studies have suggested a decreased risk of cancer in patients with diabetes on me...
OBJECTIVE - Numerous studies have suggested a decreased risk of cancer in patients with diabetes on ...
Use of metformin has been associated with a decreased cancer risk. We aimed to explore whether use o...
<p>Notes: Final model specification: estimated cumulative insulin dose, therapy (±metformin), HbA1c,...
BACKGROUND: Previous studies provide conflicting evidence on whether metformin is protective against...
Previous studies on metformin use and gastrointestinal (GI) cancer risk have yielded inconclusive re...
<p>Subgroup analysis of adjusted hazard ratios (HRs) of risk factors for metformin-related mortality...
<p>Referent group: never-users of metformin.</p><p>HR: hazard ratio, CI: confidence interval.</p><p>...
OBJECTIVEdNumerous studies have suggested a decreased risk of cancer in patients with diabetes on me...
OBJECTIVEdNumerous studies have suggested a decreased risk of cancer in patients with diabetes on me...
Whether metformin may affect thyroid cancer risk has not been studied. This study investigated the a...
BACKGROUND: Whether metformin may affect thyroid cancer risk has not been studied. This study invest...
*<p>CI denotes confidence interval.</p>†<p>The current cumulative exposure period is the number of m...
[[abstract]]BACKGROUND: Whether metformin may affect thyroid cancer risk has not been studied. This ...
*<p>CI denotes confidence interval.</p>†<p>The current cumulative exposure period is the number of m...
OBJECTIVE-Numerous studies have suggested a decreased risk of cancer in patients with diabetes on me...
OBJECTIVE - Numerous studies have suggested a decreased risk of cancer in patients with diabetes on ...
Use of metformin has been associated with a decreased cancer risk. We aimed to explore whether use o...
<p>Notes: Final model specification: estimated cumulative insulin dose, therapy (±metformin), HbA1c,...
BACKGROUND: Previous studies provide conflicting evidence on whether metformin is protective against...
Previous studies on metformin use and gastrointestinal (GI) cancer risk have yielded inconclusive re...
<p>Subgroup analysis of adjusted hazard ratios (HRs) of risk factors for metformin-related mortality...
DOI
Add to ORKG